The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy

Thyroid

Volumn 18, Issue 4, 2008, Pages 443-447

  Akaishi, Patricia Mitiko Santello ^a   Cruz, Antonio Augusto Velasco ^a   Silva, Fabricio Leon Mascaro ^a   Rodrigues, Maria De Lourdes Veronesi ^a   Maciel, Lea Maria Zanini ^a   Donadi, Eduardo Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; BRAZIL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE FREQUENCY; GENE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL;

ADULT; ALLELES; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MUSCULAR DISEASES;

EID: 42049092362     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0194     Document Type: Article

References (28)

1. Weetman A 1992 Thyroid-associated ophthalmopathy. Autoimmunity 12:215-222.
2. Rubin P, Watkins LM, Rumelt S, Sutula FC, Dallow RL 1998 Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy. Ophthalmology 105:2061-2064.
3. Nunery WR 1991 Ophthalmic Graves' disease: a dual theory of pathogenesis. Ophthalmol Clin North Am 4:73-87.
4. Trokel SL, Jakobiec FA 1981 Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 88:553-564.
5. Feldon SE, Weiner JM 1982 Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy. Arch Ophthalmol 100:1266-1269.
6. Feldon SE, Lee CP, Muramatsu SK, Weiner JM 1985 Quantitative computed tomography of Graves' ophthalmopathy. Arch Ophthalmol 103:213-215.
7. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F 1986 Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. AJNR Am J Neuroradiol 7:651-656.
8. Peyster RG, Ginsberg F, Silber JH, Adler LP 1986 Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. Am J Roentgenol 146:459-464.
9. Ohtsuka K, Nakamura Y 1998 Human leukocyte antigens associated with hyperthyroid Graves ophthalmopathy in Japanese patients. Am J Ophthalmol 126:805-810.
10. Maciel LMZ, Navarro PAAS, Rodrigues SS, Iazigi N, Donadi EA 1997 Antígenos de histocompatibilidade de classe I em pacientes brasileiros portadores da doença de Graves com ou sem oftalmopatia. Arq Bras Endocrinol Metab 41:76-81.
11. Louzada-Junior P, Smith A, Hansen J, Donadi E 2001 HLADRB1 and -DQB1 alleles in the Brazilian population of the northeastern region of the state of São Paulo. Tissue Antigens 57:158-162.
12. Bartley GB, Gorman CA 1995 Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 119:792-795.
13. Miller S, Dykes D, Polesky H 1998 A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16:1215.
14. Farid NR, Balazs C 1998 The genetics of thyroid associated ophthalmopathy. Thyroid 8:407-409.
15. Hagg E, Asplund K 1987 Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 295:634-635.
16. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 10:791-798.
17. Caweed TJ, Moriarty P, O'Farrelly C, O'shea D 2007 Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 92:59-64.
18. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR 1986 Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25:479-485.
19. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PPB, Cheah JS, Thomson G 1989 Relative predispositional effects (RPEs) of markers alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45:541-546.
20. Garrity JA, Bahn RS 2006 Pathogenesis of Graves ophthalmopathy: implications for prediction, prevention and treatment. Am J Ophthalmol 142:147-153.
21. Hiromatsu Y, Yang D, Bednarczuk T, Miyaqe I, Nonaka K, Inoue Y 2000 Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 85:1194-1199.
22. Hajeer A, Hutchinson I 2001 Influence of TNF gene polymorphisms on TNF production and disease. Hum Immunol 62:1191-1199.
23. Field M 2001 Tumor necrosis factor polymorphisms in rheumatic diseases. Q J Med 94:237-246.
24. Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J 2004 Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum Immunol 65:632-639.
25. White A, Bogh J, Leheny W, Kuchipudi P, Varghese M, al Riyami H, al Hashmi S, Daar AS 1997 HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance. Br J Ophthalmol 81:431-434.
26. Castagnoli C, Peruccio D, Stella M, Magliacani G, Mazzola G, Amoroso A, Richiardi P 1990 The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol 29:229-232.
27. - subpopulations exhibit distinct phenotypes. Eur J Immunol 32:477-485.
28. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf ) 13:535-544.